<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="a4195473-51a9-40f1-8678-1478ebca2d84"><labelDrug name="Trandate"><Normalization/></labelDrug><generic name="labetalol hydrochloride"/><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1" text="Drug Label for drug brand Trandate, containing labetalol hydrochloride." type="negative"><entity charOffset="26:34" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1.e.0" text="trandate" type="Biomedical_Entity"><Normalization><mmtx cui="C0592195" phraseText="Drug Label for drug brand Trandate," preferredWord="Trandate" semType="phsu, orch"/><RxNorm RxCui="152440"/></Normalization></entity><entity charOffset="47:70" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1.e.1" text="labetalol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0699440" phraseText="labetalol hydrochloride." preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1.e.2" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Trandate," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1.e.0" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1.e.1"/><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1.e.2" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1.e.0"/><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1.e.2" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.1.e.1"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.10" text="Dilevalol HCl is one of the four isomers of labetalol HCl. " type="negative"><entity charOffset="44:57" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.10.e.0" text="labetalol hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0699440" phraseText="one of the four isomers of labetalol HCl." preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.10.e.1" text="dilevalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0012368" phraseText="Dilevalol HCl" preferredWord="Dilevalol" semType="phsu, orch"/><RxNorm RxCui="3441"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.10.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.10.e.0"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.16" text="Although beta-blockers should be avoided in overt congestive heart failure, if necessary, labetalol HCl can be used with caution in patients with a history of heart failure who are well compensated. " type="negative"><entity charOffset="90:103" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.16.e.0" text="labetalol hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0699440" phraseText="necessary, labetalol HCl" preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="9:22" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.16.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.16.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.16.e.0"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.18" text="Labetalol HCl does not abolish the inotropic action of digitalis on heart muscle." type="negative"><entity charOffset="55:64" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.18.e.0" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="the inotropic action of digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="0:13" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.18.e.1" text="labetalol hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0699440" phraseText="Labetalol HCl" preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.18.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.18.e.0"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.21" text="If cardiac failure continues despite adequate digitalization and diuretic, therapy with TRANDATE Tablets should be withdrawn (gradually, if possible)." type="negative"><entity charOffset="88:104" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.21.e.0" text="trandate tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242564" phraseText="diuretic, therapy with TRANDATE Tablets" preferredWord="Labetalol Oral Tablet [Trandate]" semType="clnd"/><RxNorm RxCui="152440"/></Normalization></entity><entity charOffset="65:73" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.21.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic, therapy with TRANDATE Tablets" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.21.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.21.e.0"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.23" text="However, hypersensitivity to catecholamines has been observed in patients withdrawn from beta-blocker therapy, exacerbation of angina and, in some cases, myocardial infarction have occurred after abrupt discontinuation of such therapy. " type="negative"><entity charOffset="89:101" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.23.e.0" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="withdrawn from beta-blocker therapy," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="29:43" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.23.e.1" text="catecholamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0007412" phraseText="hypersensitivity to catecholamines" preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="2146"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.23.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.23.e.0"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.29" text="TRANDATE Tablets may be used with caution, however, in patients who do not respond to, or cannot tolerate, other antihypertensive agents. " type="negative"><entity charOffset="113:136" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.29.e.0" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="0:16" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.29.e.1" text="trandate tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242564" phraseText="TRANDATE Tablets" preferredWord="Labetalol Oral Tablet [Trandate]" semType="clnd"/><RxNorm RxCui="152440"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.29.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.29.e.0"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.30" text="It is prudent, if TRANDATE Tablets are used, to use the smallest effective dose, so that inhibition of endogenous or exogenous beta-agonists is minimized." type="negative"><entity charOffset="18:34" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.30.e.0" text="trandate tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242564" phraseText="TRANDATE Tablets" preferredWord="Labetalol Oral Tablet [Trandate]" semType="clnd"/><RxNorm RxCui="152440"/></Normalization></entity><entity charOffset="132:140" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.30.e.1" text="agonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0243192" phraseText="exogenous beta-agonists" preferredWord="agonists" semType="phsu"/><RxNorm RxCui="608609"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.30.e.0" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.30.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.35" lineNumber="19" text="Beta-blockade also reduces the release of insulin in response to hyperglycemia, it may therefore be necessary to adjust the dose of antidiabetic drugs." type="irregular"><entity charOffset="113:128" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.35.e.1" text="adjust the dose" type="Caution_Interaction"/><entity charOffset="132:150" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.35.e.2" text="antidiabetic drugs" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="the dose of antidiabetic drugs." preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.35.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.35.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.35.e.2"/></relation><relation type="hasObject"><labelDrug text="Trandate"/><normalization/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.35.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39" lineNumber="23" text="&lt;item&gt;A synergism between labetalol HCl and halothane anesthesia has been shown (see PRECAUTIONS: Drug Interactions)." type="regular"><entity charOffset="8:17" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.e.1" text="synergism" type="Specific_Interaction"/><entity charOffset="26:39" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.e.2" text="labetalol HCl" type="Drug"><Normalization><mmtx cui="C0699440" phraseText="A synergism between labetalol HCl" preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="44:64" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.e.3" text="halothane anesthesia" type="Drug"><Normalization><mmtx cui="C0018549" phraseText="halothane anesthesia" preferredWord="Halothane" semType="phsu, orch"/><mmtx cui="C0002932" phraseText="halothane anesthesia" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="5095"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.e.2" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.e.3" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.39.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.43" text="Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in some patients treated with alpha-1 blockers (labetalol is an alpha/beta blocker). " type="negative"><entity charOffset="149:167" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.43.e.0" text="alpha blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="an alpha/beta blocker" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="133:142" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.43.e.1" text="labetalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0022860" phraseText="(labetalol" preferredWord="Labetalol" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="115:131" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.43.e.2" text="alpha blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="treated with alpha-1 blockers" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.43.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.43.e.0"/><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.43.e.2" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.43.e.1"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.46" text="There does not appear to be a benefit of stopping alpha-1 blocker therapy prior to cataract surgery." type="negative"><entity charOffset="50:65" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.46.e.0" text="alpha blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="a benefit of stopping alpha-1 blocker therapy" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="41:49" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.46.e.1" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="a benefit of stopping alpha-1 blocker therapy" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.46.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.46.e.0"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.51" text="While no incident of the abrupt withdrawal phenomenon (exacerbation of angina pectoris) has been reported with labetalol HCl, dosing with TRANDATE Tablets should not be interrupted or discontinued without a physician's advice. " type="negative"><entity charOffset="138:154" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.51.e.0" text="trandate tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242564" phraseText="dosing with TRANDATE Tablets" preferredWord="Labetalol Oral Tablet [Trandate]" semType="clnd"/><RxNorm RxCui="152440"/></Normalization></entity><entity charOffset="111:124" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.51.e.1" text="labetalol hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0699440" phraseText="reported with labetalol HCl," preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.51.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.51.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56" lineNumber="37" text="Drug Interactions: In one survey, 2.3% of patients taking labetalol HCl in combination with tricyclic antidepressants experienced tremor, as compared to 0.7% reported to occur with labetalol HCl alone. " type="regular"><entity charOffset="130:136" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.e.1" text="tremor" type="Specific_Interaction"><Normalization><mmtx cui="C0040822" phraseText="tremor," preferredWord="Tremor" semType="sosy"/></Normalization></entity><entity charOffset="92:117" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.e.2" text="tricyclic antidepressants" type="Drug_Class"><Normalization><mmtx cui="C0003290" phraseText="with tricyclic antidepressants" preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="58:71" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.e.3" text="labetalol HCl" type="Drug"><Normalization><mmtx cui="C0699440" phraseText="labetalol HCl in combination" preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.e.3" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.e.2" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.56.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58" lineNumber="38" text="Drugs possessing beta-blocking properties can blunt the bronchodilator effect of beta-receptor agonist drugs in patients with bronchospasm, therefore, doses greater than the normal antiasthmatic dose of beta-agonist bronchodilator drugs may be required." type="regular"><entity charOffset="46:77" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.1" text="blunt the bronchodilator effect" type="Specific_Interaction"/><entity charOffset="81:108" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.2" text="beta-receptor agonist drugs" type="Drug_Class"><Normalization><mmtx cui="C0521879" phraseText="the bronchodilator effect of beta-receptor agonist drugs" preferredWord="Agonist drug" semType="phsu"/><RxNorm RxCui="38483"/></Normalization></entity><entity charOffset="126:138" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.3" text="bronchospasm" type="SPAN"><Normalization><mmtx cui="C0006266" phraseText="with bronchospasm," preferredWord="Bronchial Spasm" semType="dsyn"/></Normalization></entity><entity charOffset="0:41" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.4" text="Drugs possessing beta-blocking properties" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="Drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="151:199" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.6" text="doses greater than the normal antiasthmatic dose" type="Caution_Interaction"/><entity charOffset="203:236" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.7" text="beta-agonist bronchodilator drugs" type="Drug_Class"><Normalization><mmtx cui="C0282556" phraseText="greater than the normal antiasthmatic dose of beta-agonist bronchodilator drugs" preferredWord="Anti-Asthmatic Agents" semType="phsu"/><mmtx cui="C2987634" phraseText="greater than the normal antiasthmatic dose of beta-agonist bronchodilator drugs" preferredWord="Agonist" semType="phsu"/><mmtx cui="C0006280" phraseText="greater than the normal antiasthmatic dose of beta-agonist bronchodilator drugs" preferredWord="Bronchodilator Agents" semType="phsu"/><RxNorm RxCui="1437024"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.ddi.2"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.6"><relations><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.7"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.3" ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.4" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.2" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.4" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.7" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.58.e.6" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59" lineNumber="39" text="Cimetidine has been shown to increase the bioavailability of labetalol HCl. " type="regular"><entity charOffset="29:57" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.1" text="increase the bioavailability" type="Increase_Interaction"/><entity charOffset="0:10" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.2" text="Cimetidine" type="Drug"><Normalization><mmtx cui="C0008783" phraseText="Cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="61:74" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.3" text="labetalol HCl" type="Drug"><Normalization><mmtx cui="C0699440" phraseText="the bioavailability of labetalol HCl." preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.2" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.3" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60" lineNumber="39" text="Since this could be explained either by enhanced absorption or by an alteration of hepatic metabolism of labetalol HCl, special care should be used in establishing the dose required for blood pressure control in such patients." type="irregular"><entity charOffset="40:59" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60.e.1" text="enhanced absorption" type="Increase_Interaction"/><entity charOffset="105:118" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60.e.2" text="labetalol HCl" type="Drug"><Normalization><mmtx cui="C0699440" phraseText="or by an alteration of hepatic metabolism of labetalol HCl," preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="69:101" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60.e.4" text="alteration of hepatic metabolism" type="Specific_Interaction"/><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60.e.1"><relations><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59" text="Cimetidine has been shown to increase the bioavailability of labetalol HCl. "><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60.ddi.2"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60.e.4"><relations><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.60.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59" text="Cimetidine has been shown to increase the bioavailability of labetalol HCl. "><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.59.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61" lineNumber="40" text="Synergism has been shown between halothane anesthesia and intravenously administered labetalol HCl. " type="regular"><entity charOffset="0:9" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.e.1" text="Synergism" type="Specific_Interaction"/><entity charOffset="33:53" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.e.2" text="halothane anesthesia" type="Drug"><Normalization><mmtx cui="C0018549" phraseText="shown between halothane anesthesia" preferredWord="Halothane" semType="phsu, orch"/><mmtx cui="C0002932" phraseText="shown between halothane anesthesia" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="5095"/></Normalization></entity><entity charOffset="58:98" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.e.3" text="intravenously administered labetalol HCl" type="Drug"><Normalization><mmtx cui="C0699440" phraseText="intravenously administered labetalol HCl." preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.e.2" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.e.3" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.61.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62" lineNumber="40" text="During controlled hypotensive anesthesia using labetalol HCl in association with halothane, high concentrations (3% or above) of halothane should not be used because the degree of hypotension will be increased and because of the possibility of a large reduction in cardiac output and an increase in central venous pressure. " type="regular"><entity charOffset="92:111|146:157" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.e.1" text="high concentrations not be used" type="Caution_Interaction"/><entity charOffset="129:138" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.e.2" text="halothane" type="Drug"><Normalization><mmtx cui="C0018549" phraseText="of halothane" preferredWord="Halothane" semType="phsu, orch"/><RxNorm RxCui="5095"/></Normalization></entity><entity charOffset="47:60" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.e.3" text="labetalol HCl" type="Drug"><Normalization><mmtx cui="C0699440" phraseText="labetalol HCl in association" preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.e.3" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.e.2" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.62.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.63" text="The anesthesiologist should be informed when a patient is receiving labetalol HCl." type="negative"><entity charOffset="31:39" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.63.e.0" text="informed" type="Biomedical_Entity"><Normalization><mmtx cui="C0537670" phraseText="informed" preferredWord="Oprelvekin" semType="phsu, aapp, imft"/><RxNorm RxCui="217731"/></Normalization></entity><entity charOffset="68:81" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.63.e.1" text="labetalol hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0699440" phraseText="labetalol HCl." preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.63.e.0" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.63.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64" lineNumber="41" text="Labetalol HCl blunts the reflex tachycardia produced by nitroglycerin without preventing its hypotensive effect. " type="regular"><entity charOffset="14:43" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.e.1" text="blunts the reflex tachycardia" type="Specific_Interaction"/><entity charOffset="0:13" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.e.2" text="Labetalol HCl" type="Drug"><Normalization><mmtx cui="C0699440" phraseText="Labetalol HCl" preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="56:69" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.e.3" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="produced by nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="produced by nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.e.2" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.e.3" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.64.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65" lineNumber="41" text="If labetalol HCl is used with nitroglycerin in patients with angina pectoris, additional antihypertensive effects may occur." type="regular"><entity charOffset="78:113" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.1" text="additional antihypertensive effects" type="Specific_Interaction"/><entity charOffset="3:16" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.2" text="labetalol HCl" type="Drug"><Normalization><mmtx cui="C0699440" phraseText="labetalol HCl" preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="61:76" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.3" text="angina pectoris" type="SPAN"><Normalization><mmtx cui="C0002962" phraseText="with angina pectoris," preferredWord="Angina Pectoris" semType="sosy"/></Normalization></entity><entity charOffset="30:43" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.4" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="used with nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="used with nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.1"><relations><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.3" ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.2" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.4" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.65.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66" lineNumber="42" text="Care should be taken if labetalol is used concomitantly with calcium antagonists of the verapamil type." type="regular"><entity charOffset="0:4" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.e.1" text="Care" type="Caution_Interaction"/><entity charOffset="61:102" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.e.2" text="calcium antagonists of the verapamil type" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="concomitantly with calcium antagonists of the verapamil type." preferredWord="Calcium Channel Blockers" semType="phsu"/><mmtx cui="C0042523" phraseText="concomitantly with calcium antagonists of the verapamil type." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="24:33" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.e.3" text="labetalol" type="Drug"><Normalization><mmtx cui="C0022860" phraseText="labetalol" preferredWord="Labetalol" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.e.3" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.e.2" trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.66.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.67" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. " type="negative"><entity charOffset="5:25" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.67.e.0" text="digitalis glycosides" type="Biomedical_Entity"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="30:43" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.67.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.67.e.0" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.67.e.1"/></sentence><sentence biomedicalEntities="0" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.68" lineNumber="43" text="Concomitant use can increase the risk of bradycardia." type="irregular"><entity charOffset="41:52" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.68.e.1" text="bradycardia" type="Specific_Interaction"/><drugInteraction id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.68.ddi.1"><interaction trigger="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.68.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.67" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="30:43" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.67.e.1" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.67" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="5:25" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.67.e.0" text="digitalis glycosides" type="Drug_Class"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.69" text="Risk of Anaphylactic Reaction: While taking beta-blockers, patients with a history of severe anaphylactic reaction to a variety of allergens may be more reactive to repeated challenge, either accidental, diagnostic, or therapeutic. " type="negative"><entity charOffset="131:140" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.69.e.0" text="allergens" type="Biomedical_Entity"><Normalization><mmtx cui="C3274161" phraseText="of allergens" preferredWord="Allergen (brand of diphenylpyraline)" semType="phsu, orch"/><RxNorm RxCui="1297244"/></Normalization></entity><entity charOffset="44:57" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.69.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="taking beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.69.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.69.e.0"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.71" text="Drug/Laboratory Test Interactions: The presence of labetalol metabolites in the urine may result in falsely elevated levels of urinary catecholamines, metanephrine, normetanephrine, and vanillylmandelic acid when measured by fluorimetric or photometric methods. " type="negative"><entity charOffset="135:149" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.71.e.0" text="catecholamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0007412" phraseText="result in falsely elevated levels of urinary catecholamines," preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="2146"/></Normalization></entity><entity charOffset="51:60" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.71.e.1" text="labetalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0022860" phraseText="The presence of labetalol metabolites" preferredWord="Labetalol" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.71.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.71.e.0"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.72" text="In screening patients suspected of having a pheochromocytoma and being treated with labetalol HCl, a specific method, such as a high performance liquid chromatographic assay with solid phase extraction (e.g., J Chromatogr 385:241,1987) should be employed in determining levels of catecholamines." type="negative"><entity charOffset="84:97" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.72.e.0" text="labetalol hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0699440" phraseText="treated with labetalol HCl," preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="280:294" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.72.e.1" text="catecholamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0007412" phraseText="employed in determining levels of catecholamines." preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="2146"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.72.e.0" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.72.e.1"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73" text="Labetalol HCl has also been reported to produce a false-positive test for amphetamine when screening urine for the presence of drugs using the commercially available assay methods TOXI-LAB A (thin-layer chromatographic assay) and EMIT-d.a.u. " type="negative"><entity charOffset="0:13" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73.e.0" text="labetalol hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0699440" phraseText="Labetalol HCl" preferredWord="Labetalol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="185:188" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73.e.1" text="lab" type="Biomedical_Entity"><Normalization><mmtx cui="C0035100" phraseText="the commercially available assay methods TOXI-LAB A (thin-layer chromatographic assay" preferredWord="Chymosin" semType="phsu, aapp, enzy"/><RxNorm RxCui="151699"/></Normalization></entity><entity charOffset="74:85" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73.e.2" text="amphetamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0002667" phraseText="a false-positive test for amphetamine" preferredWord="Amphetamines" semType="phsu, orch, nsba"/><RxNorm RxCui="725"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73.e.0" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73.e.1"/><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73.e.0" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73.e.2"/><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73.e.2" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.73.e.1"/></sentence><sentence id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.75" text="When patients being treated with labetalol have a positive urine test for amphetamine using these techniques, confirmation should be made by using more specific methods, such as a gas chromatographic-mass spectrometer technique." type="negative"><entity charOffset="74:85" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.75.e.0" text="amphetamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0002667" phraseText="a positive urine test for amphetamine" preferredWord="Amphetamines" semType="phsu, orch, nsba"/><RxNorm RxCui="725"/></Normalization></entity><entity charOffset="33:42" id="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.75.e.1" text="labetalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0022860" phraseText="treated with labetalol" preferredWord="Labetalol" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><pair ddi="false" e1="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.75.e.1" e2="Dailymed.a4195473-51a9-40f1-8678-1478ebca2d84.s.75.e.0"/></sentence><positiveExamples number="11"/><negativeExamples number="23"/></document>